AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2018
Dec 10, 2018
33148_dirs_2018-12-10_95b22e45-dd79-4b68-9eec-e3243d7b35db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2018-12-06
Reporting Person: Patel Kinnari (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-06 | Common Stock | P | 5675 | $14.98 | Acquired | 5675 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 94927 | Indirect |
Footnotes
F1: The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.
More from ROCKET PHARMACEUTICALS, INC.
Merger & Acquisition
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20